Home / Tag Archives: FDA (page 4)

Tag Archives: FDA

DSFederal to Update FDA Adverse Event Reporting Tool; Sophia Parker Comments

The Food and Drug Administration has awarded DSFederal a potential $20 million contract to upgrade and maintain the agency’s Safety Reporting Portal. SRP is an online data repository that gathers and distributes information on adverse events related to regulated products to the Center for Drug Evaluation and Research,  Center for Food Safety and Applied …

Read More »

Kamal Narang: SRA to Extend Development Work for CDC-FDA Vaccine Info Database

SRA International has been awarded a potential five-year, $18 million contract to help develop and maintain applications and process data for a vaccine information system used by the Centers for Disease Control and Prevention and the Food and Drug Administration. The company will also carry out medical coding, clinical research, information technology …

Read More »

CSC Subsidiary Wins $156M to Make Anti-Nerve Gas Agent

A Computer Sciences Corp. (NYSE: CSC) subsidiary has won a $156.6 million contract from the U.S. Army to develop an agent that protects soldiers from different types of nerve gases, Nextgov reports. Bob Brewin writes DynPort Vaccine will seek Food and Drug Administration approval for the “Bioscavenger” nerve gas prophylaxis …

Read More »

CACI to Buy Health Data Analysis Firm; Dan Allen Comments

CACI International (NYSE: CACI) has agreed to acquire the healthcare data integration and analysis provider Emergint Technologies, with the transaction expected to close Dec. 1. CACI did not disclose the terms of the deal in its release. CACI estimates Emergint’s 2012 revenue at around $42 million and expects the transaction …

Read More »

GDIT Added to $500M Navy Healthcare IDIQ; Marcus Collier Comments

General Dynamics‘ (NYSE: GD) information technology business unit was awarded a position on the Omnibus III contract, which is potentially worth $497 million to all awardees, according to the company. The company said it will provide medical research support on the five-year multi-award indefinite-delivery/indefinite-quantity contract. General Dynamics said contractors will work with …

Read More »

Emergent BioSolutions Gets $1.25 Billion Contract to Supply Anthrax Vaccine

The U.S. government has selected Emergent BioSolutions Inc. (NYSE: EBS) to supply millions of doses of its anthrax vaccine over five years on a contract worth up to $1.25 billion. Contract work will begin this year and calls for Emergent to deliver a total of 44.75 million doses of BioThrax. In the …

Read More »